13F Data
13F filer · CIK 1839435

Octagon Capital Advisors LP

NEW YORK, NY · filing since Q4 2020 · last filing Aug 14, 2026
Reported value
$1.1B
+$208.9M vs prior
Positions
27
New / sold out
5 / 7
Added / reduced
4 / 6
Turnover
14.8%
buys $149.1M · sells $170.4M
Top-10 weight
78.5%

Biggest buys vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
AddedABIVAX SA+316,000+46.7%+$42.1M
AddedDEFINIUM THERAPEUTICS INC+510,000+20.9%+$24.0M
NewERASCA INCCALL+1,255,000–+$23.0M
NewSUMMIT THERAPEUTICS INC+1,250,000–+$18.2M
NewADLAI NORTYE LTD+934,716–+$10.7M
AddedPHARVARIS N V+291,721+176.8%+$10.1M
NewFAETH THERAPEUTICS INC+361,010–+$9.0M
NewGYRE THERAPEUTICS INC+954,416–+$6.3M
AddedTAYSHA GENE THERAPIES INC+833,333+9.4%+$5.7M

Biggest sells vs Q1 2026

ChangeSecurityShares changeChange %Est. trade value
Sold outCENTESSA PHARMACEUTICALS PLC-750,000-100.0%$-29.8M
Sold outKALVISTA PHARMACEUTICALS INC-1,450,000-100.0%$-29.2M
Sold outTERNS PHARMACEUTICALS INC-530,000-100.0%$-27.9M
ReducedTREVI THERAPEUTICS INC-1,170,000-78.8%$-21.8M
ReducedKYMERA THERAPEUTICS INC-115,000-27.1%$-13.2M
ReducedOCULAR THERAPEUTIX INC-1,091,600-34.5%$-10.7M
ReducedDIANTHUS THERAPEUTICS INC-105,000-5.4%$-10.2M
ReducedPRECISION BIOSCIENCES INC-886,732-39.6%$-7.0M
Sold outBRIDGEBIO ONCOLOGY THERAPEUT-719,000-100.0%$-6.4M
Sold outLEXEO THERAPEUTICS INC-1,100,000-100.0%$-6.3M
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.

Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.

Reported value by quarter

Q4 2020: $288.5MQ1 2021: $265.5MQ2 2021: $482.8MQ3 2021: $406.1MQ4 2021: $513.9MQ1 2022: $462.6MQ2 2022: $374.7MQ3 2022: $579.4MQ4 2022: $642.2MQ1 2023: $695.0MQ2 2023: $718.7MQ3 2023: $650.9MQ4 2023: $625.0MQ1 2024: $834.4MQ2 2024: $636.3MQ3 2024: $642.9MQ4 2024: $607.7MQ1 2025: $516.8MQ2 2025: $455.6MQ3 2025: $659.8MQ4 2025: $823.7MQ1 2026: $903.6MQ2 2026: $1.1B
Q4 2020Q2 2026

Holdings · Q2 2026

#SecuritySharesValueWeight
1DIANTHUS THERAPEUTICS INCCOM1,841,667$179.5M16.14%
2DEFINIUM THERAPEUTICS INCCOM SHS2,950,000$138.8M12.47%
3ABIVAX SASPONSORED ADS993,000$132.3M11.89%
4COGENT BIOSCIENCES INCCOM2,350,000$90.9M8.17%
5ALUMIS INCCOM2,830,700$79.7M7.16%
6ARRIVENT BIOPHARMA INCCOM1,971,054$68.5M6.15%
7TAYSHA GENE THERAPIES INCCOM SHS9,693,244$66.0M5.93%
8BIOAGE LABS INCCOM1,748,000$42.8M3.85%
9MIRUM PHARMACEUTICALS INCCOM338,900$39.7M3.57%
10KYMERA THERAPEUTICS INCCOM310,000$35.5M3.20%
17 more rows. Subscribe for $29/month to see every row, download the data and use the API.